Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

AIMS/HYPOTHESIS: The aim of the study was to compare the efficacy and safety of liraglutide in type 2 diabetes mellitus vs placebo and insulin glargine (A21Gly,B31Arg,B32Arg human insulin), all in combination with metformin and glimepiride. METHODS: This randomised (using a telephone or web-based ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744824/
https://www.ncbi.nlm.nih.gov/pubmed/19688338
http://dx.doi.org/10.1007/s00125-009-1472-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744824/
https://www.ncbi.nlm.nih.gov/pubmed/19688338
http://dx.doi.org/10.1007/s00125-009-1472-y

Ejemplares similares